State Of Wyoming Esperion Therapeutics, Inc. Transaction History
State Of Wyoming
- $723 Million
- Q1 2025
A detailed history of State Of Wyoming transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, State Of Wyoming holds 89,936 shares of ESPR stock, worth $168,180. This represents 0.02% of its overall portfolio holdings.
Number of Shares
89,936
Previous 46,410
93.79%
Holding current value
$168,180
Previous $102,000
26.47%
% of portfolio
0.02%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding ESPR
# of Institutions
199Shares Held
119MCall Options Held
171KPut Options Held
679K-
Black Rock Inc. New York, NY14MShares$26.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.5MShares$21.5 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT10.9MShares$20.4 Million0.09% of portfolio
-
Bellevue Group Ag Kuesnacht, V89.69MShares$18.1 Million0.32% of portfolio
-
Two Seas Capital LP Rye, NY6.93MShares$13 Million0.36% of portfolio
About Esperion Therapeutics, Inc.
- Ticker ESPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,551,600
- Market Cap $124M
- Description
- Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...